20th May 2024
Janssen Covid-19 vaccine from Johnson & Johnson.
Barcelona News Catalonia News Madrid News Main News

J&J to now delay vaccine rollout in EU – Spain prioritising it for 70-79 year olds

Latest: Coronavirus in Spain figures (19 Apr)

Report updated at 16h in Spain on 13 April

Johnson & Johnson have announced they are going to now ‘proactively delay’ the rollout of their one-shot Covid-19 vaccine in Europe. It follows the USA regulators’ recommendation to pause its use because of possible links to rare blood clots. 

In a joint statement on Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration in the USA said they were investigating blood clots in six women that occurred in the days after vaccination with Janssen doses. The clots were observed along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially ‘dangerous’.

More than 6.8 million doses of the J&J vaccine have been administered in the USA, the vast majority with no or mild side effects.

Original report below:

Spain will prioritise citizens aged between 70 and 79 for jabs against Covid-19 with Johnson & Johnson’s one-dose Janssen vaccine, and which should start arriving on Wednesday, the Spanish Health Minister Carolina Darias has said.

Spain will receive a first delivery of 300,000 doses of the vaccine on Wednesday morning, Darias told reporters at Gran Canaria airport, after a visit to the Spanish Canary Islands.

Johnson & Johnson began delivering its vaccine to EU countries on Monday, after delays due to production issues, European Union officials and the company said.

With most nursing home residents and front-line medical staff in Spain now fully vaccinated, and 90% of people over 80 years old having received a first shot, the 70-79 age group is the next priority.

Following a slow start to its vaccination campaign, Spain is betting on a surge of deliveries in the second quarter to meet its target of inoculating half the population by July.

Janssen Covid-19 vaccine from Johnson & Johnson.
Janssen Covid-19 vaccine from Johnson & Johnson.

Speaking at a press conference last Tuesday, Prime Minister Pedro Sánchez said that his government expects 25 million citizens to be fully vaccinated against Covid-19 by late July, whilst still confirming the end-August target of inoculating 70% of the population.

‘The pace of vaccination will accelerate in April and then each month we will improve the vaccination pace from the previous month,’ the prime minister said.

Between April and September the government expects 87 million vaccine doses, while deliveries in the second quarter are expected to be 3.5 times what the country received in January through March.

Up to Monday 12 April, Spain had received a total of 11,993,715 doses of Covid-19 vaccines (7,717,515 from Pfizer-BioNTech, 1,044,000 from Moderna and 3,232,200 from AstraZeneca). A total of 10,784,997 jabs have now been administered (553,172 more since Friday), representing 89.9% of total doses received. 3,108,437 people have now received a second jab (36,328 more since Friday), representing 6.6% of the population. Click here for full details: Covid-19 vaccinations in Spain

Also read: Coronavirus in Spain figures (12 Apr)

Sign up for the FREE Weekly Newsletter from Spain in English.

Please support Spain in English with a donation.

Click here to get your business activity or services listed on our DIRECTORY.

Click here for further details on how to ADVERTISE with us.

Recent Posts

British Embassy: ‘Get the TIE now’ – ahead of EU’s Entry Exit System coming into force

News Desk

Three Spanish tourists killed by gunmen in Afghanistan’s Bamyan province

News Desk

Pedro Sánchez: socialist win in Catalonia ‘ends decade of division and resentment’

News Desk

Sale of Vodafone’s Spanish division for up to €5 billion receives green light

News Desk

Catalan amnesty bill back to Spanish Congress after ‘symbolic’ veto in Senate

News Desk

Ukrainian President Zelensky cancels trip to Spain and Portugal

News Desk

Leave a Comment